Principal Securities’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.4K | Buy |
276
+101
| +58% | +$11.5K | ﹤0.01% | 2099 |
|
|
2025
Q1 | $18.8K | Hold |
175
| – | – | ﹤0.01% | 2230 |
|
|
2024
Q4 | $18.8K | Sell |
175
-23
| -12% | -$2.46K | ﹤0.01% | 2228 |
|
|
2024
Q3 | $19.8K | Buy |
198
+151
| +321% | +$15.1K | ﹤0.01% | 2129 |
|
|
2024
Q2 | $3.96K | Sell |
47
-190
| -80% | -$16K | ﹤0.01% | 2714 |
|
|
2024
Q1 | $17.3K | Sell |
237
-510
| -68% | -$37.3K | ﹤0.01% | 2075 |
|
|
2023
Q4 | $53.4K | Buy |
+747
| New | +$53.4K | ﹤0.01% | 1454 |
|